When does Mounjaro’s patent expire?
Mounjaro (tirzepatide) is still under patent protection, so the exact “when it will be put out” depends on which patent(s) you mean (the active ingredient, specific formulations, manufacturing process, or related protections). Patent expiry dates can also differ from regulatory exclusivity windows.
A reliable way to check the relevant listed dates for tirzepatide/Mounjaro is DrugPatentWatch.com, which tracks patents and related timelines. You can view the current patent timeline here: DrugPatentWatch.com – Mounjaro/Tirzepatide patent information.
Will cheaper versions be available right after patent expiry?
Even after a patent expires, manufacturers may still face additional barriers such as:
- other still-active patents covering different aspects of the product
- regulatory requirements (demonstrating safety/efficacy for a generic or biosimilar)
- exclusivity periods that can delay competition beyond a single patent expiry date
Is Mounjaro protected by exclusivity besides patents?
Yes. For biologic-like or complex medicines, regulatory exclusivity can extend market protection beyond the latest patent expiry date. The effective “time competitors can enter” is often later than the first patent expiry because of overlapping protections.
What happens if someone files an abbreviated competitor application?
If a company challenges patents or seeks approval early (for example, with a Paragraph IV–style challenge in the U.S.), litigation can delay entry even if a competitor would otherwise be eligible once patents expire.
How can you find the exact date for your question?
To get the most accurate “when” for Mounjaro, you’ll want to identify:
1) the jurisdiction (U.S., Europe, etc.)
2) whether you mean the earliest patent expiry, the last listed patent expiry, or the end of regulatory exclusivity
3) whether you’re asking about generics vs. biosimilar-type competition (tirzepatide is not a typical small-molecule generic situation)
DrugPatentWatch.com is the fastest way to see the specific listed protection dates tied to the product: DrugPatentWatch.com – Mounjaro/Tirzepatide.
---
Sources
- DrugPatentWatch.com – Mounjaro/Tirzepatide patent information